Crossmark

Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice

Crossref DOI link: https://doi.org/10.1186/s13024-018-0288-y

Published Online: 2018-10-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beel, Sander

Herdewyn, Sarah

Fazal, Raheem

De Decker, Mathias

Moisse, Matthieu

Robberecht, Wim

Van Den Bosch, Ludo

Van Damme, Philip http://orcid.org/0000-0002-4010-2357
Funding

Funding for this research was provided by:

ALS Therapy Alliance
License Information

Text and Data Mining valid from 2018-10-16
More Information

Article History

Received: 3 April 2018

Accepted: 3 October 2018

First Online: 16 October 2018

Ethics approval

: The study was approved by the Ethical Committee of the KU Leuven (P148/2011).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.